Yang Valerie Shiwen, Lim Jing Quan, Tay Timothy Kwang Yong, Selvarajan Sathiyamoorthy, Ng Cedric Chuan-Young, Farid Mohamad, Teh Bin Tean, Chan Jason Yongsheng
Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Institute of Molecular and Cell Biology, Singapore.
J Immunother Precis Oncol. 2020 Apr 28;3(2):90-95. doi: 10.36401/JIPO-19-34. eCollection 2020 May.
Primary osteosarcoma (OS) of the uterus is a distinctly rare and aggressive disease with fewer than 20 cases reported worldwide. We describe a case of primary uterine OS with rapid development of pulmonary and brain metastasis in a 50-year-old woman. Histopathologic examination of the uterine tumor showed atypical spindle cells producing an osteoid matrix with calcification in keeping with OS. Despite initial response to doxorubicin and ifosfamide, the patient succumbed to brain metastases just 8 months from diagnosis. Whole genome sequencing was performed on tumor and blood samples to analyze genetic alterations in this highly aggressive tumor. A pathogenic somatic missense mutation resulting in substitution of glutamate for lysine at position 653 within the protein kinase domain of the platelet-derived growth factor receptor beta () was found. The PDGF pathway is involved in cell proliferation and angiogenesis, and it has been implicated in malignancy. Crucially, this pathogenic mutation may be amenable to PDGFR tyrosine kinase inhibition, representing a possible treatment approach in this rare sarcoma.
子宫原发性骨肉瘤(OS)是一种极为罕见且侵袭性强的疾病,全球报道的病例不足20例。我们描述了一例50岁女性原发性子宫OS,其肺部和脑转移迅速发展。子宫肿瘤的组织病理学检查显示非典型梭形细胞产生骨样基质并伴有钙化,符合骨肉瘤表现。尽管对多柔比星和异环磷酰胺最初有反应,但患者在诊断后仅8个月就死于脑转移。对肿瘤和血液样本进行了全基因组测序,以分析这种高度侵袭性肿瘤的基因改变。发现了一种致病性体细胞错义突变,该突变导致血小板衍生生长因子受体β(PDGFRβ)蛋白激酶结构域第653位的赖氨酸被谷氨酸取代。PDGF途径参与细胞增殖和血管生成,并且与恶性肿瘤有关。至关重要的是,这种致病性突变可能适合PDGFR酪氨酸激酶抑制,这代表了这种罕见肉瘤的一种可能治疗方法。